Form 4: Blend Labs Head of Revenue Sells 30,000 Shares Under 10b5-1 Plan

Brian Kneafsey, Head of Revenue at Blend Labs, sold 30,000 shares of Class A Common Stock on January 14, 2025, at a weighted average price of $3.4083 per share, according to a pre-arranged 10b5-1 trading plan.

Summary

• Brian Kneafsey, Head of Revenue at Blend Labs, sold 30,000 shares of Class A Common Stock on January 14, 2025.
• The sales were executed under a Rule 10b5-1 trading plan adopted on September 12, 2024.
• The weighted average sale price was $3.4083 per share, with prices ranging from $3.35 to $3.48.
• Following the transaction, Kneafsey directly owns 836,759 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating an insider stock sale. The use of a 10b5-1 plan suggests the sale was pre-planned and doesn't necessarily reflect a negative outlook on the company. Therefore, the sentiment is neutral.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any specific non-public information. Investors often monitor insider transactions for signals about a company's prospects, but sales under 10b5-1 plans are generally viewed as less informative.

Comparison to Industry Standards

• It's difficult to compare this specific transaction to industry standards without knowing the size of Kneafsey's overall holdings and the typical trading patterns of executives at comparable companies.
• However, the use of a 10b5-1 plan is a common practice among corporate executives to avoid accusations of insider trading.
• Companies like Palantir, Snowflake, and Datadog have seen similar insider selling activity, often under pre-arranged trading plans.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates